Monterey Private Wealth’s Edwards Lifesciences EW Stock Holding History

Monterey Private Wealth’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,330	Closed	-$220K	–	98
2023 Q2	$220K	Buy	+2,330	New	+$203K	0.11%	97
2022 Q2	–	Sell	-1,995	Closed	-$234K	–	106
2022 Q1	$234K	Sell	1,995 -1,200	-38%	-$135K	0.11%	106
2021 Q4	$414K	Hold	3,195	–	–	0.21%	67
2021 Q3	$348K	Hold	3,195	–	–	0.2%	65
2021 Q2	$331K	Buy	3,195 +87	+3%	+$8.2K	0.19%	69
2021 Q1	$298K	Hold	3,108	–	–	0.16%	73
2020 Q4	$284K	Hold	3,108	–	–	0.16%	67
2020 Q3	$248K	Hold	3,108	–	–	0.16%	72
2020 Q2	$215K	Buy	+3,108	New	+$221K	0.15%	68
2020 Q1	–	Sell	-3,561	Closed	-$277K	–	67
2019 Q4	$277K	Buy	+3,561	New	+$278K	0.22%	58

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Monterey Private Wealth's EW Position: Q3 2023 in Review

Monterey Private Wealth sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 2,330 shares — an estimated $220K sold.

Monterey Private Wealth first reported a position in EW in Q4 2019 and held it in 10 quarters. The position peaked at $414K in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

Monterey Private Wealth reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
Monterey Private Wealth sold 2,330 Edwards Lifesciences shares in Q3 2023, an estimated $220K.
Monterey Private Wealth first reported a position in Edwards Lifesciences in Q4 2019 and held it in 10 quarters.
Monterey Private Wealth's Edwards Lifesciences position peaked at $414K in Q4 2021.
1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Monterey Private Wealth's 13F filing for Q3 2023, filed 10 Oct 2023.